Enjosim

Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals.

Sales and marketing Health and bio Logistics and mobility

Latest funding

$30.08M Series B+ · November 2, 2026

Led by CICC · Source: donews.com

Funding history ↓

Website: enjosim.com.

Categories: Sales and marketing Health and bio Logistics and mobility.

Sectors: Biopharma, Medical, Medical Device.

Stage: Series B+.

Based in: Shanghai, China.

Last round: Nov 2, 2026 · 10 days ago.

On Recent Funding since: Nov 3, 2026.

Signals

Website registeredSep 23, 2022 (4 years old)

Funding rounds

November 2, 2026
Series B+ · $30.08M
CCICC (lead), CCo-Stone Venture Capital, HHosenCare Brothers, QQiming Venture Partners, WWuxi Yingyue Private Equity Fund Management, ZZhuhai Science and Technology Industry Group
Source: donews.com
September 23, 2022
Website created

Investors

Companies like Enjosim

ZzerothirdSeed · Mar 2026
RRheos MedicalSeed · Oct 2026
LLinux Laboratories$70M Series B+ · Sep 2026
HHybron$25M Seed · Apr 2026
DDP4Pre Seed · Feb 2026
EEmber LifeSciences$27M Series A · May 2026

Other companies backed by CICC

ZZhishu Technology$29.96M Series B+ · Oct 2026
NNeolix$400M Series B+ · Oct 2026
YYarbo$27M Series B+ · May 2025
KKingsware$72.4M Series B+ · Mar 2023
ZZhenye New MaterialsSeries A · Nov 2026
LLinyi YunchuanSeed · Nov 2026

CICC portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/enjosim (get a free API key).